aberkenblit Profile Banner
Anna Berkenblit, MD, MMSc Profile
Anna Berkenblit, MD, MMSc

@aberkenblit

Followers
200
Following
289
Media
22
Statuses
191

Chief Scientific & Medical Officer @PanCAN đź’ś | Biotech Executive | Oncologist | Drug Developer

Joined April 2013
Don't wanna be here? Send us removal request.
@aberkenblit
Anna Berkenblit, MD, MMSc
2 days
🏷️ @Novocure.
0
0
0
@aberkenblit
Anna Berkenblit, MD, MMSc
2 days
🧵 It’s encouraging to see at #ESMOGI25 that the additional quality-of-life outcomes and the post-hoc analysis of time to first opioid use align with the positive data previously presented at #ASCO25 from the Phase 3 PANOVA-3 Trial of TTFields in #pancreaticcancer.
1
0
1
@aberkenblit
Anna Berkenblit, MD, MMSc
3 days
Cutting resources threatens ongoing research and risks deterring future scientists. Congress must prioritize cancer research funding to sustain progress against this deadly disease.
@PanCAN
PanCAN
4 days
This is the devastating reality facing leading cancer researchers right now, as shared in a recent @CBSNews story. Dr. Elizabeth Jaffee, deputy director of the @hopkinskimmel and an Emeritus Member of PanCAN’s Scientific and Medical Advisory Board, recently joined other top
Tweet media one
0
0
1
@aberkenblit
Anna Berkenblit, MD, MMSc
3 days
A compelling read explaining the allure of liquid biopsies to screen for #cancer while also breaking down the associated complexities to provide a more nuanced understanding of where we're at and how far we have to go.
0
0
0
@aberkenblit
Anna Berkenblit, MD, MMSc
3 days
Excellent @NewYorker article by @DrSidMukherjee exploring challenges of #cancer early detection, including #pancreaticcancer.
1
1
2
@aberkenblit
Anna Berkenblit, MD, MMSc
3 days
At @PanCAN, we are driven by the urgency to improve outcomes for patients facing one of the deadliest cancers. This collaboration with @AcurionInc exemplifies how we can leverage cutting-edge AI with rich, real-world data to advance precision medicine in #pancreaticcancer.
@PanCAN
PanCAN
3 days
We're thrilled to announce a new data partnership with @AcurionInc, a leader in AI-driven oncology diagnostics, aimed at transforming how #pancreaticcancer is sub-typed for optimal treatment selection. Using data from PanCAN’s SPARK platform and Acurion’s OncoGaze™ technology,.
0
0
1
@aberkenblit
Anna Berkenblit, MD, MMSc
9 days
RT @Immuneering: Guided by our goal to help people with #cancer live longer and feel better, we are deeply honored to support @PanCAN as a….
0
6
0
@aberkenblit
Anna Berkenblit, MD, MMSc
9 days
RT @Aiims1742: Yoshi Majima (founder of @PanCAN Japan) has been a passionate advocate for patients & families for over two decades. He talk….
0
7
0
@aberkenblit
Anna Berkenblit, MD, MMSc
9 days
PanCAN is excited to partner with @LetsWinPC on the new PancChat Podcast! Ep. 1 is live now, featuring @PanCAN President & CEO @JulieFleshman — and stay tuned for Ep. 2 next week, where I’ll join @drallysonocean to discuss the latest in #pancreaticcancer research.
@PanCAN
PanCAN
9 days
We’re thrilled to have partnered with @letswinpc for the PancChat Podcast, a collaborative effort from Let’s Win Pancreatic Cancer and the Pancreatic Cancer Action Network (PanCAN), inspired by the long-running #PancChat Twitter/X chat. 💬🎙️. Hosted by award-winning journalist
0
1
3
@aberkenblit
Anna Berkenblit, MD, MMSc
9 days
RT @UGrewalMD: Thank you so much for reviewing and discussing our work. It’s been so wonderful collaborating with @PanCAN on this project.….
0
4
0
@aberkenblit
Anna Berkenblit, MD, MMSc
10 days
1
1
3
@aberkenblit
Anna Berkenblit, MD, MMSc
10 days
In this month’s @PanCAN Research Spotlight, I’m highlighting key takeaways on #pancreaticcancer from the #ASCO25 Annual Meeting. Read more:
Tweet media one
1
3
13
@aberkenblit
Anna Berkenblit, MD, MMSc
10 days
RT @PanCAN: In this month’s Research Spotlight, PanCAN’s Chief Scientific and Medical Officer, Dr. @ABerkenblit shares new insights from th….
0
5
0
@aberkenblit
Anna Berkenblit, MD, MMSc
24 days
Mark your calendar and reserve your virtual seat today!.
@PanCAN
PanCAN
1 month
PanCAN Patient Services is a lifeline for people facing #pancreaticcancer. Every call or email we receive, our Case Managers are there, ready to provide support, offer resources and more — often becoming a trusted partner for patients and families as they navigate this
Tweet media one
Tweet media two
0
1
4
@aberkenblit
Anna Berkenblit, MD, MMSc
24 days
We at @PanCAN encourage all patients with #pancreaticcancer to undergo tumor biomarker testing and genetic testing for inherited mutations to determine if there are any alterations that may impact treatment decisions.
0
0
1
@aberkenblit
Anna Berkenblit, MD, MMSc
24 days
Nice work out of the Tuveson lab @CSHL in @CR_AACR exploring FGFR2 inhibition to slow the growth of #pancreaticcancer, especially in its early stages.
1
1
3
@aberkenblit
Anna Berkenblit, MD, MMSc
24 days
Attention researchers! Apply today:
@PanCAN
PanCAN
29 days
ATTN Researchers! ‼️ The Congressionally Directed Medical Research Program at the Department of Defense has announced five funding opportunities are now available through the FY25 Peer Reviewed Cancer Research Program (PRCRP), with pancreatic cancer as a topic area. This is
Tweet media one
0
0
4
@aberkenblit
Anna Berkenblit, MD, MMSc
24 days
My sincere thanks to @JulieFleshman, @WorldPCC Chair and President and CEO of @PanCAN, for the invitation and the opportunity to engage with this extraordinary global community, and to @AstellasUS and @Novartis for their continued support of the coalition.
0
0
2
@aberkenblit
Anna Berkenblit, MD, MMSc
24 days
With member organizations representing more than 30 countries worldwide, it was inspiring to hear about the diverse and impactful ways in which they are addressing #pancreaticcancer in their respective regions. 🌎
Tweet media one
1
0
1
@aberkenblit
Anna Berkenblit, MD, MMSc
24 days
It was a true pleasure to join the @WorldPCC for their annual Member Gathering yesterday and to present on the State of the Pancreatic Cancer Field.
Tweet media one
1
2
5